A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)

Magnetic resonance imaging (MRI) is commonly used in healthcare, and sometimes it shows small areas of brain damage called Covert Brain Infarcts (CBIs). These are usually found by chance when people have scans for things like headaches or dizziness. Although CBIs don't cause symptoms at the time, they are linked to a higher risk of future stroke and death. There is currently no standard treatment for CBIs, and doctors have different approaches-some give stroke-preventing medication (like antiplatelets or statins), while others don't treat at all. This is mostly because there isn't enough research yet. This study will test whether stroke-preventing treatments help people with CBIs. It will also look at whether having a CBI increases the risk of dementia, and whether treatment might lower that risk.

NCT Number	NCT07012629
Lead Sponsor	Aarhus University Hospital Collaborators: Rigshospitalet, Denmark, Bispebjerg Hospital, Herlev Hospital, Zealand University Hospital, Odense University Hospital, Aalborg University Hospital, Gødstrup Hospital, Oslo University Hospital, Universitätsklinikum Hamburg-Eppendorf, Insel Gruppe AG, University Hospital Bern, Lund University Hospital
Conditions	Covert Brain Infarction
Enrollment	1,652 participants
Start Date	2025-11-26
Primary Completion	2031-09-30 (estimated)
Study Completion	2040-01-01 (estimated)
Updated on ClinicalTrials.gov	2025-12-04